KR101505415B1 - 이소포스포르아미드 머스타드의 염 및 이의 동족체 - Google Patents

이소포스포르아미드 머스타드의 염 및 이의 동족체 Download PDF

Info

Publication number
KR101505415B1
KR101505415B1 KR1020097023032A KR20097023032A KR101505415B1 KR 101505415 B1 KR101505415 B1 KR 101505415B1 KR 1020097023032 A KR1020097023032 A KR 1020097023032A KR 20097023032 A KR20097023032 A KR 20097023032A KR 101505415 B1 KR101505415 B1 KR 101505415B1
Authority
KR
South Korea
Prior art keywords
ipm
delete delete
tris
dose
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020097023032A
Other languages
English (en)
Korean (ko)
Other versions
KR20090130098A (ko
Inventor
존 씨. 아메디오
바바라 피. 월너
필립 비. 코마르니트스키
Original Assignee
지오팜 온콜로지 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39387443&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101505415(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 지오팜 온콜로지 인코포레이티드 filed Critical 지오팜 온콜로지 인코포레이티드
Publication of KR20090130098A publication Critical patent/KR20090130098A/ko
Application granted granted Critical
Publication of KR101505415B1 publication Critical patent/KR101505415B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/24—Esteramides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/24—Esteramides
    • C07F9/2454—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2458—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of aliphatic amines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Seasonings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
KR1020097023032A 2007-04-06 2008-04-04 이소포스포르아미드 머스타드의 염 및 이의 동족체 Expired - Fee Related KR101505415B1 (ko)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US92214807P 2007-04-06 2007-04-06
US60/922,148 2007-04-06
US92736307P 2007-05-02 2007-05-02
US60/927,363 2007-05-02
US93491407P 2007-06-15 2007-06-15
US60/934,914 2007-06-15
US123707P 2007-10-30 2007-10-30
US61/001,237 2007-10-30
PCT/US2008/004449 WO2008124097A2 (en) 2007-04-06 2008-04-04 Salts of isophosphoramide mustard and analogs thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020137008586A Division KR101604244B1 (ko) 2007-04-06 2008-04-04 이소포스포르아미드 머스타드의 염 및 이의 동족체

Publications (2)

Publication Number Publication Date
KR20090130098A KR20090130098A (ko) 2009-12-17
KR101505415B1 true KR101505415B1 (ko) 2015-03-25

Family

ID=39387443

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020097023032A Expired - Fee Related KR101505415B1 (ko) 2007-04-06 2008-04-04 이소포스포르아미드 머스타드의 염 및 이의 동족체
KR1020157033501A Withdrawn KR20150139620A (ko) 2007-04-06 2008-04-04 이소포스포르아미드 머스타드의 염 및 이의 동족체
KR1020137008586A Expired - Fee Related KR101604244B1 (ko) 2007-04-06 2008-04-04 이소포스포르아미드 머스타드의 염 및 이의 동족체

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020157033501A Withdrawn KR20150139620A (ko) 2007-04-06 2008-04-04 이소포스포르아미드 머스타드의 염 및 이의 동족체
KR1020137008586A Expired - Fee Related KR101604244B1 (ko) 2007-04-06 2008-04-04 이소포스포르아미드 머스타드의 염 및 이의 동족체

Country Status (22)

Country Link
US (2) US8604007B2 (https=)
EP (2) EP2581367B1 (https=)
JP (1) JP5659010B2 (https=)
KR (3) KR101505415B1 (https=)
CN (2) CN101679265B (https=)
AU (1) AU2008236684B2 (https=)
BR (1) BRPI0809999A2 (https=)
CA (1) CA2684747A1 (https=)
CY (1) CY1116596T1 (https=)
DK (2) DK2155682T3 (https=)
ES (1) ES2547302T3 (https=)
HU (1) HUE025949T2 (https=)
IL (2) IL201424A (https=)
MX (1) MX2009010820A (https=)
NZ (1) NZ580341A (https=)
PL (1) PL2155682T3 (https=)
PT (2) PT2581367E (https=)
RU (1) RU2527531C2 (https=)
SI (1) SI2155682T1 (https=)
TW (2) TWI490226B (https=)
WO (1) WO2008124097A2 (https=)
ZA (1) ZA200907722B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2336140B1 (en) * 2004-10-25 2016-01-27 Dekk-Tec, Inc. Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
US7964583B2 (en) * 2006-02-17 2011-06-21 Ziopharm Oncology, Inc. Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
MX2009010820A (es) 2007-04-06 2010-03-18 Ziopharm Oncology Inc Sales de mostaza isofosforamida y analogos de la misma.
NZ601139A (en) * 2008-07-31 2014-02-28 Ziopharm Oncology Inc Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof
AU2010218109B2 (en) * 2009-02-24 2015-04-09 Dekk-Tec, Inc. Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents
US20130196000A1 (en) * 2012-01-31 2013-08-01 Ziopharm Oncology, Inc. Combination therapy including isophosphoramide mustard, analogs, or salts thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006047575A2 (en) * 2004-10-25 2006-05-04 Dekk-Tec Inc. Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU427945A1 (ru) 1972-07-24 1974-05-15 Институт элементоорганических соединений СПОСОБ ПОЛУЧЕНИЯа ПОЛИФТОРАЛКИЛЗАМЕЩЕННЫХБЕНЗИЛДИХЛОРФОСФАТОВ
JPS5159886A (https=) 1974-11-20 1976-05-25 Shionogi Seiyaku Kk
US4537883A (en) * 1982-11-12 1985-08-27 Mead Johnson & Company Lyophilized cyclophosphamide
US5091552A (en) 1986-06-30 1992-02-25 Board Of Regents, The University Of Texas System Novel antitumor aldophosphamide analogs
US5055459A (en) * 1986-06-30 1991-10-08 Board Of Regents, The University Of Texas Selective elimination of malignant cells from bone marrow by bis (acyloxy) propylphosphoramidates
US5204335A (en) * 1986-10-31 1993-04-20 Asta Pharma Aktiengesellschaft Ifosfamide lyophilisate and process for its preparation
CA2130578A1 (en) 1992-04-17 1993-10-28 Geewananda P. Gunawardana Taxol derivatives
US5468499A (en) * 1993-11-15 1995-11-21 Ohio State University Liposomes containing the salt of phosphoramide mustard and related compounds
US5659061A (en) * 1995-04-20 1997-08-19 Drug Innovation & Design, Inc. Tumor protease activated prodrugs of phosphoramide mustard analogs with toxification and detoxification functionalities
EP0795334B1 (de) * 1996-03-12 2006-02-01 Sanofi-Aventis Deutschland GmbH Neuartige Prodrugs für die Therapie von Tumoren und entzündlichen Erkrankungen
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
DE60007120T2 (de) 1999-05-24 2004-09-16 Southern Research Institute, Birmingham Isophosphoramide-senfgasanalogen und deren verwendung
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
GB2378948B (en) 2000-04-13 2004-11-10 Hsc Res Dev Lp Novel compounds for modulating cell proliferation
EP2186811A1 (en) 2002-08-23 2010-05-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
MX2009010820A (es) 2007-04-06 2010-03-18 Ziopharm Oncology Inc Sales de mostaza isofosforamida y analogos de la misma.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006047575A2 (en) * 2004-10-25 2006-05-04 Dekk-Tec Inc. Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents

Also Published As

Publication number Publication date
MX2009010820A (es) 2010-03-18
CN102942589B (zh) 2016-04-20
ZA200907722B (en) 2010-11-24
TWI490226B (zh) 2015-07-01
KR20090130098A (ko) 2009-12-17
EP2155682A2 (en) 2010-02-24
PT2581367E (pt) 2016-03-28
NZ580341A (en) 2012-06-29
JP5659010B2 (ja) 2015-01-28
CA2684747A1 (en) 2008-10-16
IL201424A0 (en) 2010-05-31
CY1116596T1 (el) 2017-03-15
JP2010523571A (ja) 2010-07-15
SI2155682T1 (sl) 2015-11-30
KR20130041391A (ko) 2013-04-24
AU2008236684A1 (en) 2008-10-16
CN101679265B (zh) 2014-10-29
AU2008236684B2 (en) 2013-04-18
IL223353A (en) 2016-02-29
US9340563B2 (en) 2016-05-17
EP2581367A2 (en) 2013-04-17
TW201406772A (zh) 2014-02-16
US8604007B2 (en) 2013-12-10
BRPI0809999A2 (pt) 2014-10-14
DK2581367T3 (en) 2016-03-14
KR101604244B1 (ko) 2016-03-17
PL2155682T3 (pl) 2015-12-31
CN102942589A (zh) 2013-02-27
TW200906842A (en) 2009-02-16
US20140194377A1 (en) 2014-07-10
CN101679265A (zh) 2010-03-24
EP2581367B1 (en) 2015-12-30
US20080255056A1 (en) 2008-10-16
DK2155682T3 (en) 2015-09-21
EP2581367A3 (en) 2013-07-03
IL201424A (en) 2016-02-29
WO2008124097A3 (en) 2008-12-24
PT2155682E (pt) 2015-10-15
HUE025949T2 (en) 2016-05-30
RU2527531C2 (ru) 2014-09-10
IL223353A0 (en) 2013-02-03
ES2547302T3 (es) 2015-10-05
RU2009140904A (ru) 2011-05-20
EP2155682B1 (en) 2015-06-24
KR20150139620A (ko) 2015-12-11
TWI501972B (zh) 2015-10-01
WO2008124097A2 (en) 2008-10-16

Similar Documents

Publication Publication Date Title
US8795659B2 (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
KR101505415B1 (ko) 이소포스포르아미드 머스타드의 염 및 이의 동족체
ES2565069T3 (es) Sales de mostaza de isofosforamida y análogos de las mismas
AU2011221388B2 (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
HK1185884A (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
HK1100945B (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A107 Divisional application of patent
A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20180319

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20180319